NIH Blueprint Neurotherapeutics: SBIR U44 funding for biologic therapies for nervous/neuromuscular disorders, preclinical to Phase 1
NIH’s BPN Biologics program funds small businesses to advance biologic therapies (e.g., antibodies, peptides, oligonucleotides, gene and cell therapies) for nervous and neuromuscular disorders. Using a milestone-driven U44 Fast-Track, projects can progress from lead optimization and IND-enabling work to optional first-in-human Phase 1 trials, with access to NIH guidance and optional CRO suppor…
Source
Dates
Eligibility
Keywords
Supporting Links
Documents
Similar Opportunities
Get the full picture on this opportunity
Create a free Scout account to unlock everything you need to decide fast and win the grant.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Deep agency & funder detail
Program context, sub-agency structure, and a full eligibility breakdown.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Similar opportunities
Discover related funding matched to your work.
Already have an account? Sign In
Trusted by 500+ Happy Customers